1-42927224-G-T
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_006516.4(SLC2A1):c.1296C>A(p.Tyr432*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Y432Y) has been classified as Likely benign.
Frequency
Consequence
NM_006516.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- encephalopathy due to GLUT1 deficiencyInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- GLUT1 deficiency syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- childhood onset GLUT1 deficiency syndrome 2Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
- dystonia 9Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- epilepsy, idiopathic generalized, susceptibility to, 12Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary cryohydrocytosis with reduced stomatinInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- myoclonic-astatic epilepsyInheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006516.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC2A1 | NM_006516.4 | MANE Select | c.1296C>A | p.Tyr432* | stop_gained | Exon 10 of 10 | NP_006507.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC2A1 | ENST00000426263.10 | TSL:1 MANE Select | c.1296C>A | p.Tyr432* | stop_gained | Exon 10 of 10 | ENSP00000416293.2 | ||
| SLC2A1 | ENST00000630287.2 | TSL:5 | n.*611C>A | non_coding_transcript_exon | Exon 9 of 9 | ENSP00000486694.1 | |||
| SLC2A1 | ENST00000674545.1 | n.1913C>A | non_coding_transcript_exon | Exon 2 of 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Encephalopathy due to GLUT1 deficiency Pathogenic:1
not provided Pathogenic:1
GLUT1 deficiency syndrome 1, autosomal recessive Pathogenic:1
This variant disrupts a region of the SLC2A1 protein in which other variant(s) (p.Arg458Trp) have been determined to be pathogenic (PMID: 23280796, 23340081, 28116237). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 193689). This premature translational stop signal has been observed in individual(s) with GLUT1 deficiency syndrome 1 (PMID: 29303961). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr432*) in the SLC2A1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 61 amino acid(s) of the SLC2A1 protein. For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at